Published

Molecule of the Month: Psilocybin and Mescaline

No abstract is available for this record.

Open source BibTeX RIS

Bibliographic context

Journal: Unknown
Date: 1999-09-30
Source: OpenAlex
DOI: Unavailable
PubMed: Unavailable

Authors

Paul May

Watch author

Topics and keywords

psilocybin General Other Mescaline Psilocybin Hallucinogen Psychology Psychiatry Psychedelics and Drug Studies Chemical synthesis and alkaloids

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Avoiding Stigma and Sensationalism in Therapeutic Psilocybin Communications: Considerations for Reaching Older PatientsAmerican Journal of Geriatric Psychiatry · 2025-07-22 Irremediable Psychiatric Suffering, a Potential Indication for Psilocybin TreatmentAmerican Journal of Psychiatry · 2025-02-28 Case Report: Repeated low doses of psilocybin reduce perceived symptom severity but fail to restore cognitive flexibility in a case of severe obsessive-compulsive disorder: an observational case study of identical twinsFrontiers in Psychiatry · 2026-04-20 Psychedelics in NHS services: exploring a model for real-world implementation of psilocybinThe British Journal of Psychiatry · 2026-03-29 Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulationsPsychiatry and Clinical Neurosciences · 2026-02-25 Psilocybin Outside the ClinicJAMA Psychiatry · 2025-11-04 Short- and long-term modulation of rat prefrontal cortical activity following single doses of psilocybinMolecular Psychiatry · 2025-08-25 Psilocybin-assisted psychotherapy as a rapid-acting treatment for cancer-related depression and anxiety: Evidence from a network meta-analysisThe International Journal of Psychiatry in Medicine · 2025-04-24